Stockscreener 앱 받기
10.25
1.63%
-0.17
시간 외 거래:
10.25
Solid Biosciences Inc 주식(SLDB)의 최신 뉴스
Solid Biosciences Stock Price Forecast. Should You Buy SLDB? - StockInvest.us
Solid Biosciences LLC (NASDAQ: SLDB) Share Price, SLDB Stock News, SLDB Share Price & Updates - Kalkine
Solid Biosciences Insiders Sell US$823k Of Stock, Possibly Signalling Caution - simplywall.st
Solid Biosciences to Participate at Upcoming Investor Conferences - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO), LeonaBio (LONA) and Solid Biosciences (SLDB) - The Globe and Mail
Cantor raises Solid Biosciences stock price target on gene therapy - Investing.com
Cantor Fitzgerald Maintains Solid Biosciences(SLDB.US) With Buy Rating, Raises Target Price to $26 - Moomoo
Solid Biosciences Inc (SLDB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SLDB Maintained by Truist Securities -- Price Target Raised to $20 - GuruFocus
Solid Biosciences (NASDAQ:SLDB) Earns Buy Rating from Analysts at Truist Financial - MarketBeat
Solid Biosciences (NASDAQ:SLDB) Stock Price Down 6.7%Time to Sell? - MarketBeat
Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Solid Biosciences Inc. brings patient advocates to FA panel at GMP Lab - Traders Union
Perceptive Advisors (NASDAQ: SLDB) details 11.2% beneficial stake and warrant limits - Stock Titan
Solid Biosciences (SLDB): Vestal Point Capital discloses 4.8% ownership, including warrant shares - Stock Titan
Solid Biosciences (SLDB) Holds Steady Near $9.09 as Gene Therapy Sector Watches Key LevelsVolume Weighted Price - vinanet.vn
HC Wainwright Has Positive Estimate for SLDB Q3 Earnings - MarketBeat
Form 8K Solid Biosciences LLC For: 6 August By Investing.com - Investing.com Nigeria
J.P. Morgan Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Dimensional Fund Advisors LP Acquires 277,051 Shares of Solid Biosciences Inc. $SLDB - MarketBeat
Solid Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Citizens reiterates Solid Biosciences stock rating on pipeline progress By Investing.com - Investing.com Nigeria
Citizens reiterates Solid Biosciences stock rating on pipeline progress - Investing.com
Solid Biosciences (NASDAQ:SLDB) Posts Earnings Results, Beats Estimates By $0.08 EPS - MarketBeat
Solid Biosciences Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
Solid Biosciences Inc. Stock 12‑Month Price Target Cut to $17.64, Implies 102% Upside - TradingView
Solid Biosciences Inc (SLDB) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Solid Biosciences files prospectus for up to $200 million at-the-market stock offering - Bitget
Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates - The Manila Times
Solid Biosciences (SLDB) Eyes Key Clinical Milestones Amid High Valuation on Price-to-Sales Basis - GuruFocus
Solid Biosciences files prospectus supplement for up to $200 million stock offering - Investing.com Canada
Solid Biosciences (NASDAQ: SLDB) sets $200M stock sale capacity - Stock Titan
Solid Biosciences Q2 net loss widens on higher R&D costs - TradingView
Solid Biosciences Inc. Q2 2026: Revenue $0 Net loss $(54.8M), EPS $(0.38) — 10-Q Summary - TradingView
FMR LLC and Abigail Johnson (SLDB) disclose 7% beneficial stake in Solid Biosciences - Stock Titan
BlackRock, Inc. Expands Solid Biosciences (SLDB) Stake with Stra - GuruFocus
Solid Biosciences (SLDB) Expected to Release Quarterly Earnings on Tuesday - MarketBeat
Janus Henderson Group PLC Acquires Shares of 4,010,695 Solid Biosciences Inc. $SLDB - MarketBeat
SLDB|Solid Biosciences Inc|Price:8.080|Chg%:+0.020 - TradingKey
BlackRock (SLDB holder) discloses 6.5% Solid Biosciences stake in Schedule 13G - Stock Titan
Solid Biosciences Inc. $SLDB Shares Purchased by Ally Bridge Group NY LLC - MarketBeat
SLDB|Solid Biosciences Inc|Price:7.830|Chg%:-0.150 - TradingKey
Solid Biosciences Inc (SLDB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Solid Biosciences Inc (SLDB) Income Statement - TradingKey
Solid Biosciences Inc. (NASDAQ:SLDB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Solid Biosciences Inc (SLDB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Solid Biosciences Inc (SLDB) Cash Flow - TradingKey
Solid Biosciences Inc (SLDB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Solid Biosciences (SLDB) Proxy filing Summary - Quartr
SLDB stock trades around recent lows as Solid Biosciences updates gene therapy pipeline - Ad-hoc-news.de
Solid Biosciences Slips 3.65% as Biotech Headwinds Weigh on SLDBRTH Profile - dars.gov.et
Solid Biosciences (SLDB) Registration filing Summary - Quartr
Solid Biosciences (SLDB) AGM 2026 Summary - Quartr
Solid Biosciences (SLDB) Q4 2025 earnings summary - Quartr
Solid Biosciences (SLDB) Declines Over 6% as Selling Pressure BuildsIV Contraction - dars.gov.et
How Investors May Respond To Solid Biosciences (SLDB) Joining Multiple Russell Growth Indices - Sahm
0.86%
0.31%
자본화:
|
볼륨(24시간):